SHUKRAPHAR

Healthcare Drug Manufacturers - Specialty & Generic

★ Watchlist ⧉ Add to bucket

₹82.07

+0.6% today · 30d +22.51%

as of 2026-11-09

Price · Daily Candles

Detect candlestick pattern

AI narrative is temporarily unavailable for SHUKRAPHAR. The deterministic sections below render from live data.

₹ Latest Earnings · Q ending 2026-09-30

REVENUE

₹44 Cr

NET PROFIT

₹13 Cr

OPM

43.05%

EPS

₹0.29

PE 105.36

◇ Sector Position

PEERPEROCE %

SHUKRAPHAR105.36—

SUNPHARMA37.7921.44

DIVISLAB93.121.56

ZYDUSLIFE28.424.22

+ 2 more peers — sign in to view

ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

SCORE / 100

Overall

6-axis composite of the sections below.

Performance — —

Valuation STRETCHED 5

Growth STEADY 54

Profitability HIGH 100

Technicals NEUTRAL 52

Risk LOW 90

Key Stats

TTM PE

105.36

P/B

39.25

52W HIGH

₹84.5

OFF HIGH

-2.88%

DIV YIELD

0.01%

◉ Active Signals

MACDBullish0.4622

RSI(14)Bearish77.59

Near 52W HighBullish-2.88

⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold SHUKRAPHAR and at what entry.